Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Esophageal Cancer Patients”

1,308 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,308 results

Not applicableLooking for participantsNCT06440174
What this trial is testing

Understanding the Variation of Modern Endoscopic Ultrasound Use in Patients With Oesophageal Cancer (VALUE)

Who this might be right for
Oesophageal Cancer
University Hospital Southampton NHS Foundation Trust 160
Testing effectiveness (Phase 2)Study completedNCT00759226
What this trial is testing

Chemotherapeutic Trial With Gemcitabine, Cisplatin, 5-FU and Folinic Acid in Esophageal Cancer

Who this might be right for
Esophageal Cancer
CONKO-Studiengruppe 92
Large-scale testing (Phase 3)Study completedNCT03957590
What this trial is testing

Investigate Tislelizumab (BGB-A317) Versus Placebo in Combination With Concurrent Chemoradiotherapy in Participants With Localized Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
BeiGene 370
Early research (Phase 1)Study completedNCT00199849
What this trial is testing

NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine

Who this might be right for
Prostate CancerBladder CancerNon-small Cell Lung Cancer+2 more
Ludwig Institute for Cancer Research 18
Not applicableStudy completedNCT03032224
What this trial is testing

Analysis of Body Composition in Relation to Outcome After Surgery in a Cohort of Patients With Esophageal Cancer

Who this might be right for
Cancer of EsophagusGastric Cancer
Vastra Gotaland Region 76
Not applicableUnknownNCT06068127
What this trial is testing

G-POEM for Refractory Gastroparesis After Esophagectomy With Gastric Pull-through

Who this might be right for
GastroparesisEsophageal Cancer
Institute for Clinical and Experimental Medicine 30
Large-scale testing (Phase 3)Study completedNCT00270166
What this trial is testing

The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy

Who this might be right for
AnemiaMultiple MyelomaLymphoma+6 more
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 201
Testing effectiveness (Phase 2)Study completedNCT00971841
What this trial is testing

Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Advanced or Recurrent Esophageal Cancer

Who this might be right for
Esophageal Cancer
Bristol-Myers Squibb 1
Testing effectiveness (Phase 2)Looking for participantsNCT06819566
What this trial is testing

Prophylactic Endoscopic Variceal Ligation in Patients With High-risk Esophageal Varices Receiving Atezo/Bev for HCC

Who this might be right for
Hepatocellular CarcinomaEsophageal VarixBleeding Esophageal Varices
Asan Medical Center 44
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07196345
What this trial is testing

TAS-102 Plus Radiotherapy in Elderly ESCC

Who this might be right for
ESCCTAS 102Radiotherapy
Qianfoshan Hospital 45
Not applicableLooking for participantsNCT05443841
What this trial is testing

Value of Pleural Lavage Cytology in Resectable Esophageal Carcinoma Eastern Cooperative Thoracic Oncology Projects 2005, ECTOP-2005)

Who this might be right for
Esophageal Cancer
Fudan University 385
Early research (Phase 1)Study completedNCT03518554
What this trial is testing

A First in Human, Dose Escalation Study of JAB-3068 （SHP2 Inhibitor） in Adult Patients With Advanced Solid Tumors

Who this might be right for
Non-small Cell Lung CancerHead and Neck CancerEsophageal Cancer+1 more
Jacobio Pharmaceuticals Co., Ltd. 38
Not applicableStudy completedNCT04301986
What this trial is testing

Patient Acceptance and Preference Among Screening Modalities for Detection of Barrett's Esophagus

Who this might be right for
Barrett EsophagusGERD
University of North Carolina, Chapel Hill 24
Not applicableStudy completedNCT02435602
What this trial is testing

The Role of Chromoendoscopy in the Early Detection of Esophageal Cancer in Patients With Prior Head and Neck Cancers

Who this might be right for
Esophageal Squamous Cell CarcinomaSquamous Cell Carcinoma of the Head and Neck
Maria Sklodowska-Curie National Research Institute of Oncology 294
Testing effectiveness (Phase 2)Study completedNCT04732494
What this trial is testing

Anti-PD-1 Monoclonal Antibody Tislelizumab (BGB-A317) Combined With or Without Anti-TIGIT Monoclonal Antibody Ociperlimab (BGB-A1217) in Participants With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
BeiGene 125
Testing effectiveness (Phase 2)Looking for participantsNCT03539822
What this trial is testing

Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies

Who this might be right for
Gastric CancerEsophageal AdenocarcinomaHepatocellular Carcinoma+1 more
Anwaar Saeed 117
Testing effectiveness (Phase 2)Active Not RecruitingNCT03488667
What this trial is testing

Perioperative mFOLFOX Plus Pembrolizumab in Gastroesophageal Junction (GEJ) and Stomach Adenocarcinoma

Who this might be right for
Gastro Esophageal Junction CancerStomach CancerAdenocarcinoma
University of Kansas Medical Center 40
Early research (Phase 1)UnknownNCT02970539
What this trial is testing

Ph1b Study of Oraxol in Comb. w. Ramucirumab in Patients w. Gastric, Gastro-esophageal, or Esophageal Cancers

Who this might be right for
Gastric CancerEsophageal CancerGastro-esophageal Cancer
Athenex, Inc. 36
Early research (Phase 1)Not Yet RecruitingNCT06748872
What this trial is testing

EPITOME-1015-I: a Study to Investigate the Safety and Tolerability of MDG1015 in Patients with Epithelial Ovarian Cancer, Gastroesophageal Adenocarcinoma, Round Cell Liposarcoma And/or Synovial Sarcoma

Who this might be right for
Epithelial Ovarian CancerGastro-esophageal Junction CancerSoft Tissue Sarcoma (STS)+2 more
Medigene AG 55
Testing effectiveness (Phase 2)Ended earlyNCT00570531
What this trial is testing

Phase II Trial for Patients With Loco-Regional Esophageal Carcinoma

Who this might be right for
Loco-regional Esophageal Cancer
University of Michigan Rogel Cancer Center 6
Load More Results